• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Rupture (2208)
Event Date 06/01/2016
Event Type  Injury  
Manufacturer Narrative
The pipeline devices will not be returned for evaluation as they remain implanted in the patients.Based on the reported information, there did not appear to have been any defect of the devices during use.The events occurred in the patients post-procedure and its cause could not be conclusively determined from the reported information.Petr, o.(2016).Current trends and results of endovascular treatment of unruptured intracranial aneurysms at a single institution in the flow-diverter era.American journal of neuroradiology, 37(6), 1106-1113.Doi:10.3174/ajnr.A4699 mdrs related to this article: 2029214-2016-00627 2029214-2016-00628.
 
Event Description
Medtronic received information from literature review of complications after pipeline implantation.The purpose of this article was to review the results of endovascular treatment.The 122 patients with 129 aneurysms were treated with flow diverters (124 treated with pipeline embolization device; 5 with another manufacturer's flow diversion device.) of the patients, 104 were female and the mean age was 55.7 years.The mean aneurysm size was 12.3mm it was reported that one patient had post-treatment rupture of a giant left ica aneurysm 11 months after pipeline implantation.It was also reported that another patient underwent partial coiling and pipeline implantation of a left posterior communicating artery aneurysm.The aneurysm ruptured 9.1 months after implantation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key5835926
MDR Text Key50813391
Report Number2029214-2016-00627
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 07/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/01/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/06/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-